Coya Therapeutics (COYA) Current Deferred Revenue (2023 - 2025)
Historic Current Deferred Revenue for Coya Therapeutics (COYA) over the last 3 years, with Q3 2025 value amounting to $916712.0.
- Coya Therapeutics' Current Deferred Revenue rose 5995.98% to $916712.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $916712.0, marking a year-over-year increase of 5995.98%. This contributed to the annual value of $848286.0 for FY2024, which is 810.55% down from last year.
- As of Q3 2025, Coya Therapeutics' Current Deferred Revenue stood at $916712.0, which was up 5995.98% from $731075.0 recorded in Q2 2025.
- In the past 5 years, Coya Therapeutics' Current Deferred Revenue registered a high of $939035.0 during Q2 2024, and its lowest value of $573089.0 during Q3 2024.
- Moreover, its 3-year median value for Current Deferred Revenue was $844850.0 (2024), whereas its average is $807798.6.
- Examining YoY changes over the last 5 years, Coya Therapeutics' Current Deferred Revenue showed a top increase of 5995.98% in 2025 and a maximum decrease of 2214.61% in 2025.
- Quarter analysis of 3 years shows Coya Therapeutics' Current Deferred Revenue stood at $923109.0 in 2023, then dropped by 8.11% to $848286.0 in 2024, then increased by 8.07% to $916712.0 in 2025.
- Its Current Deferred Revenue was $916712.0 in Q3 2025, compared to $731075.0 in Q2 2025 and $841414.0 in Q1 2025.